Gurry Investments, a Boston-based investment firm established in 2000, is using its technology to produce organic fertilizer using waste from farmed fish. The company, working with fertilizer producer Multi Bloom and Mega Green, which is owned by Consolidated Catfish of Isola, Miss., uses a hydrolysis process. The skin and bones are removed from filleted fish, leaving the protein. The offal is ground into a slurry form, processed and separated in a three-stage centrifuge. The result is a product with 10 percent high quality fish oil and 4 percent sediment, which is used as ground cover, hydrolysate or organic fertilizer.

According to Carl Reetz, president of Gurry Investments, using fish waste for organic fertilizer instead of fishmeal or fish oil can benefit both processors and the seafood industry as a whole.

More info

Some 30 million NOK are to be made available for new initiatives alongside continuing support for established programmes such as MABIT and Marbank.

The Canadian facility has a battery of reactors and support utilities that enable it to operate multi-tonne scale fermentations under industrial conditions. During the project it produced sufficient biomass for Photonz to complete development of the downstream purification processes for its EPA product, also at pilot industrial scale.

More info

When producing omega-3 concentrates, all omega-3-fatty acids are preserved. In fish oil there is also a rather large amount of saturated fat which from a nutritional point of view, is not interesting for further production. Using distillation, these saturated fats are being separated from the process. The waste of fatty acids can be used as biodiesel and replace today’s fuel oil. The Norwegian Climate and Pollution Agency has approved our replacement of fuel oil with self-produced biodiesel.

Biodiesel from fish oils is a renewable resource, and even though the emission of  CO2 will be the same, it will be CO2 neutral in the cycle considering the accounting/final statement of greenhouse gasses.

GC Rieber Oils is expecting a reduction of fuel oil of approximately 25% in 2011. Our target is  a 100% replacement of fuel oil.

More info

In discussing the new Oceans line with Leif Gjendemsjø, founder and Managing Director of Pharma Marine, he explained, “Our goal with the Oceans line is to use the trimmings from seafood processing, which occurs before seafood reaches restaurants and stores. In the interest of sustainability, we believe that using these byproducts, which would have otherwise been wasted, is preferable to using targeted fish that are exclusively sourced for omega-3 production.”

More info

To assist with the launch, Source-Omega provides exclusive marketing and distribution rights under Source-Omega’s license and sole-source agreements to Novamed Singapore, starting January 1st 2012.

“CereNate is A Mother’s Gift For Life,” said Mr Tiang Sung Ann, Director of Sales and Marketing at Novamed. Singapore has a growing economy with clinics serving Halal preferred populations seeking vegetarian capsules for omega-3 oils. CereNate conforms to international standards to provide 300mg DHA for pregnant and nursing women. In Singapore, it will be the first DHA product made entirely from plant-based sources. Tiang and Novamed bring ten years of corporate experience serving the omega-3 markets in Singapore.

More info

Neptune’s recently issued U.S. patent (U.S. No. 8,030,348) covers, regardless of the extraction process, novel omega-3 fatty acid phospholipid compositions suitable for human consumption, synthetic and/or natural, including compositions extracted from marine and aquatic biomasses. The 8,030,348 patent protects Neptune Krill Oil (NKO(R)) and also covers amongst others, oils and powders extracted from krill, containing marine phospholipids bonded to EPA and/or DHA, distributed and/or sold in the U.S. market.

More info

The omega-3 sector continues to expand, according to Packaged facts data.

More info

The transaction is expected to close in the third quarter of 2011.  Financial terms of the transaction were not disclosed.

Scanbio is headquartered in Trondheim, Norway, and its fish protein concentrate, fish meal and fish oil are produced from white and pelagic fish and salmon by-products and are primarily sold into the aquaculture fish feed, animal feed and bio-fuel markets.  Scanbio’s business addresses the growing global market demand for protein ingredients for animal feed sourced from the sustainable processing of fish by-products.

Following the Paine & Partners transaction, Carl Eide will assume the position of Chief Executive Officer of Scanbio.  Per Arne Eide will retire as Chief Executive Officer, but will remain involved with the company and will have a seat on the Scanbio Board of Directors.

More info

The study, published in the Journal of Agricultural and Food Chemistry, reports that blood plasma glucose, insulin, and lipid concentrations are enhanced, whilst insulin sensitivity is improved in mice fed a diet rich in marine derived long-chain monounsaturated fatty acids (MUFAs).

“This study demonstrates that fish-oil-derived MUFA ingestion reduces insulin resistance, as judged by the insulin tolerance test, and attenuates metabolic syndrome by improving hyperglycemia, hyperinsulinemia, and hyperlipidemia,” wrote the study authors, led by Zhi-Hong Yang, from the Tokyo Innovation Center, Japan.

“Furthermore, intake of MUFA decreased obesity-induced inflammation by suppressing … inflammatory marker genes and arachidonic acid levels, thereby possibly, in turn, reducing insulin resistance in diet-induced obese mice,” they added.

More info